May 8, 2009

SIGA Technologies to Announce First Quarter 2009 Results of Operations On May 14, 2009

NEW YORK, May 8, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, plans to announce its first quarter 2009 results in a press release that will be issued on Thursday, May 14, 2009 before the market open. The Company has scheduled a conference call and simultaneous webcast to discuss the results at 9:30 am EDT on Thursday, May 14, 2009.

Participants should call 877-879-6174 (United States/Canada) or 719-325-4761 (International) and request the SIGA Technologies call or utilize the confirmation code 8844376. A live broadcast of the earnings conference call will also be available via the Internet at During the call, there will be a question-and-answer session open to analysts and institutional investors. The Company will also take a limited number of questions by email at The deadline for submitting questions is Wednesday, May 13, 2009 at 12:00 pm EDT.

If you are unable to participate, an audio replay of the call will be available beginning two hours after the call and will be available until 11:59 p.m. on Thursday, May 21, 2009, by dialing 888-203-1112 (domestic) or 719-457-0820 (international) using replay pass code 8844376. The webcast of the event will also be archived on the Company's website for one year.

About SIGA Technologies, Inc.

SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential bio-warfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA's Web site at

The SIGA Technologies, Inc. logo is available at

This news release was distributed by GlobeNewswire,

SOURCE: SIGA Technologies, Inc.

KCSA Strategic Communications
          Todd Fromer
          Marybeth Csaby

(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.

News Provided by COMTEX

Close window | Back to top

Copyright 2017 SIGA